Skip to content
Search

Latest Stories

Invatech Health sells its care homes electronic medication administration system to PCS

Health technology pioneer Invatech Health has sold its care homes electronic medication administration record (eMAR) system Atlas to care home management specialists Person Centred Software (PCS).

Following the transition of Atlas to new ownership, Bristol-based Invatech Health will concentrate solely on further growth of Titan, its cutting-edge software for pharmacy management.


Invatech Health CEO Tariq Muhammad, a pharmacist who started working on care homes back in 2002, first conceived the concept of electronic medicines system for care homes in 2006.

Muhammad said he was proud to see his purpose-driven business given an opportunity for further progress. “It’s a bit like being at a child’s graduation,” he said, after the completion of the acquisition which marked the end of a 20 year journey for him with Atlas.

“I set up Atlas to tackle a dire need in the care homes sector for a system which could prevent incorrect dosing, mismanagement of prescriptions and administration errors of important medication.

“For me Atlas has always been about the end user – care homes and their residents. It’s taken a long time to perfect it and, as with any business, there have been bumps along the way.

"Now I’ve taken Atlas as far as I can, so I’m delighted to see it under new ownership, with a company whose values I share and who can allow it to reach greater heights as part of a new ecosystem.

“It’s a clean acquisition, with a complete continuation in staffing and functionality, so it couldn’t have happened any better for all involved.

“My management team and I will oversee the transition over coming months to ensure Atlas is properly bedded in. We can then focus all our efforts into the exciting development of Titan – a similarly cutting-edge product and the equivalent in the rapidly-growing pharmacy sector.

“The potential for Titan is massive. So while I’ve seen one brainchild flying the nest today, there’s another one growing rapidly which needs our full attention.”

PCS, which is based in Guildford in Surrey, confirmed that as part of the acquisition it would retain Atlas’s full team of 15 staff, all of whom work remotely.

Atlas is currently deployed in 700 care homes across the UK, and serviced by a 165-strong network of independent pharmacies, now has the opportunity to be further implemented across PCS’s client base of 3,000 care homes in total.

Jonathan Papworth, co-founder of PCS, said: “I have been impressed with the proven capabilities built into Atlas, alongside the unique level of integration across GPs and pharmacies.

“Atlas is joining our family of social care products to provide best-in-class clinical software for our global customers, from digital care records to medication management and beyond.

“This will provide our joint customers with the opportunity to have full interoperability across our products, as well as the most comprehensive and capable integration with healthcare systems.”

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less